VANCOUVER, BC, Dec. 21, 2023 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that as part of BioVaxys' efforts to refocus on ...
BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps
VANCOUVER, British Colombia and BARCELONA, Spain, Dec. 19, 2022 /PRNewswire/ - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback